Genetic markers for PTSD risk and resilience among survivors of the World Trade Center attacks

Disease Markers

Volumn 30, Issue 2-3, 2011, Pages 101-110

  Sarapas, Casey ^a   Cai, Guiqing ^b   Bierer, Linda M ^c   Golier, Julia A ^c   Galea, Sandro ^d   Ising, Marcus ^e   Rein, Theo ^e   Schmeidler, James ^c   Müller Myhsok, Bertram ^e   Uhr, Manfred ^e   Holsboer, Florian ^e   Buxbaum, Joseph D ^b   Yehuda, Rachel ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d Columbia University ^*  (United States)

^e MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

Author keywords

childhood trauma; cortisol; FKBP5 protein; gene expression; genotype; human; post traumatic; September 11 terrorist attacks; Stress disorders

Indexed keywords

GLUCOCORTICOID RECEPTOR; HYDROCORTISONE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; NUCLEAR FACTOR I; STAT5B PROTEIN;

ADULT; ARTICLE; BRAIN FUNCTION; CELL FUNCTION; CLINICAL ARTICLE; DISEASE SEVERITY; DNA POLYMORPHISM; FEMALE; FKBP5 GENE; FOLLOW UP; GENE; GENE EXPRESSION; GENE LOCUS; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC MARKER; GENOTYPE; HOMOZYGOSITY; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; IMMUNOCOMPETENT CELL; MALE; MICROARRAY ANALYSIS; POPULATION RESEARCH; POSTTRAUMATIC STRESS DISORDER; PRIORITY JOURNAL; RISK ASSESSMENT; SURVIVAL RATE; TERRORISM; WORLD TRADE CENTER ATTACK;

EID: 79955125328     PISSN: 02780240     EISSN: 18758630     Source Type: Journal    
DOI: 10.3233/DMA-2011-0764     Document Type: Article

References (41)

1. N.R. Nugent, A.B. Amstadter and K.C. Koenen, Genetics of post-traumatic stress disorder: Informing clinical conceptual-izations and promoting future research, American Journal of Medical Genetics. Part C, Seminars in Medical Genetics 148 (2008), 127-132. (Pubitemid 351705129)
2. B.F. Broekman, M. Olff and F. Boer, The genetic background to PTSD. Neuroscience andBiobehavioral Reviews 31 (2007), 348-362. (Pubitemid 46241450)
3. R. Yehuda, G. Cai, J.A. Golier, C. Sarapas, S. Galea, M. Ising, T. Rein, J. Schmeidler, B. Müller-Myhsok, M. Uhr, F. Holsboer and J.D. Buxbaum, Gene expression patterns associated with PTSD following exposure to the World Trade Center attacks, Biological Psychiatry 66 (2009), 708-711.
4. R.H. Segman, N. Shefi, T. Goltser-Dubner, N. Friedman, N. Kaminski and A.Y. Shalev, Peripheral blood mononuclear cell gene expression profiles identify emergent post-traumatic stress disorder among trauma survivors, Molecular Psychiatry 10 (2005), 500-513, 425. (Pubitemid 40646438)
5. E. B. Binder, R.G. Bradley, W. Liu, M.P Epstein, T.C. Deveau, K.B. Mercer, Y. Tang, CF. Gillespie, CM. Heim, CB. Ne-meroff, A.C. Schwartz, J.F. Cubells andK.J. Ressler, Associa-tion ofFKBP5 polymorphisms and childhood abuse with risk of posttraumatic stress disorder symptoms in adults, Journal oftheAmerican Medical Association 299 (2008), 1291-1305. (Pubitemid 351439075)
6. P. Xie, H.R. Kranzler, J. Polling, M.B. Stein, R.F. Anton, L.A. Farrer and J. Gelernter, Interaction of FKBP5 with childhood adversity on risk for post-traumatic stress disorder, Neuropsy-chopharmacology 35 (2010), 1684-1692.
7. K.C. Koenen, G. Saxe, S. Purcell, J.W. Smoller, D. Bartholomew, A. Miller, E. Hall, J. Kaplow, M. Bosquet, S. Moulton and C. Baldwin, Polymorphisms in FKBP5 are as-sociated with peritraumatic dissociation in medically injured children, Molecular Psychiatry 10(2005), 1058-1059. (Pubitemid 43251094)
8. E.R. de Kloet, M Joels and F. Holsboer, Stress and the brain: from adaptation to disease, Nature Review ofNeuroscience 6 (2005), 463-475. (Pubitemid 40769171)
9. R. Yehuda, Status ofglucocorticoid alterations in posttraumat-ic stress disorder, Annals oftheNew York Academy ofSciences 1179 (2009), 56-69.
10. D.L. Delahanty, A.J. Raimonde and E. Spoonster, Initial post-traumatic urinary cortisol levels predict subsequent PTSD symptoms in motor vehicle accident victims, Biological Psy-chiatry 48 (2000), 940-947.
11. H.S. Resnick, R. Yehudaand R. Acierno, Acutepost-rapeplas-ma cortisol, alcohol use, and PTSD symptom profile among recent rape victims, Annals ofthe New York Academy ofSciences 821 (1997), 433-436. (Pubitemid 27343040)
12. R. Yehuda and L.M. Bierer, Transgenerational transmission of cortisol and PTSD risk, Progress in Brain Research 167 (2008), 121-135.
13. R. Yehuda, S.M. Engel, S.R. Brand, J. Seckl, S.M. Marcus and G.S. Berkowitz, Transgenerational effects of posttraumatic stress disorder in babies of mothers exposed to the World Trade Center attacks during pregnancy, Journal ofClinical Endocrinology andMetabolism 90 (2005), 4115-4118 (Pubitemid 41058182)
14. M. Kellner, R. Yehuda, J. Arlt and K. Wiedemann, Longitudi-nal course ofsalivary cortisol in post-traumatic stress disorder, Acta Psychiatrica Scandinavica 2 (2002), 153-156.
15. R. Yehuda, A. Morris, E. Labinsky, S. Zemelman and J. Schmeidler, Ten-year follow-up study ofcortisol levels in ag-ing holocaust survivors with and without PTSD, Journal of Traumatic Stress 5 (2007), 757-761. (Pubitemid 350144883)
16. K.L. Jang, S. Taylor, M.B. Stein and S. Yamagata, Trau-ma exposure and stress response: exploration of mechanisms of cause and effect, Twin Research and Human Genetics 10 (2007), 564-572. (Pubitemid 47327018)
17. S. Galea, J. Ahern, H. Resnick, D. Kilpatrick, M. Bucuvalas, J. Gold and D. Vlahov, Psychological sequelae ofthe September 11 terrorist attacks in New York City, New England Journal ofMedicine 346 (2002), 982-987. (Pubitemid 34983249)
18. D.D. Blake, F.W. Weathers, L.M. Nagy, D.G. Kaloupek, F.D. Gusman, D.S. Charney and T.M. Keane, The development of a clinician-administered PTSD scale, Journal of Traumatic Stress 8 (1995), 75-90.
19. R.L. Spitzer, M. Gibbonand J.B.W. Williams, Structured Clin-ical Interview for DSM-IVAxis 1Disorders (SCID). New York State Psychiatric Institute, Biometrics Research, New York, 1995.
20. E. Foa, L. Cashman, L. Jaycox and K. Perry, The validation of a self-report measure of posttraumatic stress disorder: the Posttraumatic Diagnostic Scale, Psychological Assessment 9 (1997), 445-451. (Pubitemid 28137200)
21. S. Debey, T. Zander, B. Brors, A. Popov, R. Eils and J.L. Schultze, A highly standardized, robust, and cost-effective method for genome-wide transcriptome analysis ofperipheral blood applicable to large-scale clinical trials, Genomics 87 (2006), 653-664.
22. J. Liu, E. Walter, D. Stenger and D. Thach, Effects of globin mRNA reduction methods on gene expression profiles from whole blood, Journal ofMolecular Diagnostics 8 (2006), 551-558. (Pubitemid 44774153)
23. K.J. Preacher and A.F. Hayes, SPSS and SAS procedures for estimating indirect effects in simple mediation models, Behavior Research Methods, Instruments, and Computers 36 (2004), 717-731. (Pubitemid 40251423)
24. J.M. McClellan, E. Susser and M.C. King, Schizophrenia: a common disease caused by multiple rare alleles, British Journal ofPsychiatry 190 (2007), 194-199. (Pubitemid 46384001)
25. A. Biola, P. Lefebvre, M. Perrin-Wolff, M. Sturm, J. Bertoglio and M. Pallardy, Interleukin-2 inhibits glucocorticoid receptor transcriptional activity through a mechanism involving STAT5 (signal transducer and activator oftranscription 5) but not AP-1, Molecular Endocrinology 15 (2001), 1062-1076. (Pubitemid 32614062)
26. E. Goleva, K.O. Kisich and D.Y Leung, A role for STAT5 inthe pathogenesis of IL-2-induced glucocorticoid resistance, Journal of Immunology 169 (2002), 5934-5940. (Pubitemid 35291700)
27. PB. Hebbar and T.K. Archer, Chromatin-dependent coopera-tivity between site-specific transcription factors in vivo, Journal ofBiological Chemistry 282 (2007), 8284-8291. (Pubitemid 47093548)
28. S. Galea, D. Vlahov, H. Resnick, J. Ahern, E. Susser, J. Gold, M. Bucuvalas and D. Kilpatrick, Trends of probable post-traumatic stress disorder inNew York City afterthe September 11 terrorist attacks, American Journal ofEpidemiology 158 (2003), 514-524. (Pubitemid 37093227)
29. J. Zieker, D. Zieker, A. Jatzko, J. Dietzsch, K. Nieselt, A. Schmitt, T. Bertsch, K. Fassbender, R. Spanagel, H. Northoff and PJ. Gebicke-Haerter, Differential gene expression in pe-ripheral blood of patients suffering from post-traumatic stress disorder, Molecular Psychiatry 12 (2007), 116-118. (Pubitemid 46160977)
30. F. Holsboer, How can we realize the promise of personalized antidepressant medicines, Nature Review ofNeuroscience 9 (2008), 638-646.
31. E.B. Binder, D. Salyakina, P. Lichtner, G.M. Wochnik, M. Ising, B. Pütz, S. Papiol, S. Seaman, S. Lucae, M.A. Kohli, T. Nickel, H.E. Künzel, B. Fuchs, M. Majer, A. Pfennig, N. Kern, J. Brunner, S. Modell, T. Baghai, T. Deiml, P. Zill, B. Bondy, R. Rupprecht, T. Messer, O. Köhnlein, H. Dabitz, T. Brückl, N. Müller, H. Pfister, R. Lieb, J.C. Mueller, E. Lõhmussaar, TM. Strom, T. Bettecken, T. Meitinger, M. Uhr, T. Rein, F. Holsboer and B. Muller-Myhsok, Polymorphisms in FKBP5 are associated with increased recurrence of depres-sive episodes and rapid response to antidepressant treatment, Nature Genetics 36 (2004), 1319-1325. (Pubitemid 39577942)
32. R. Yehuda, S.L. Halligan, J.A. Golier, R. Grossman and L.M. Bierer, Effects oftrauma exposure on the cortisol response to dexamethasone administration in PTSD and major depressive disorder, Psychoneuroendocrinology 29 (2004), 389-404. (Pubitemid 37487955)
33. D.L. Riggs, P.J. Roberts, S.C. Chirillo, J. Cheung-Flynn, V. Prapapanich, T. Ratajczak, R. Gaber, D. Picardand D.F. Smith, The Hsp90-binding peptidylprolyl isomerase FKBP52 poten-tiates glucocorticoid signaling in vivo, The EMBO Journal 22 (2003), 1158-1167. (Pubitemid 36313599)
34. G.M. Wochnik, J. Rüegg, G.A. Abel, U. Schmidt, F. Hols-boer and T. Rein, FKBP51 and FKBP52 differentially regu-late dynein interaction and nuclear translocation ofthe gluco-corticoid receptor in mammalian cells, Journal of Biological Chemistry 280 (2005), 4609-4616. (Pubitemid 40288629)
35. CF. Gillespie, J. Phifer, B. Bradley and K. Ressler, Risk and resilience: genetic and environmental influences on develop-ment ofthe stress response, Depression andAnxiety 26 (2009), 984-992.
36. V.L. Willour, H. Chen, J. Toolan, P. Belmonte, DJ. Cutler, F.S. Goes, PP. Zandi, R.S. Le, D.F. Mac Kinnon, F.M. Mondimore and B. Schweizer, Bipolar Disorder Phenome Group, NIMH Genetics Initiative Bipolar Disorder Consortium, J.R. De Paulo, Jr., E.S. Gershon, FJ. McMahon and J.B. Potash, Family-based association of FKBP5 in bipolar disorder, Molecular Psychiatry 14 (2009), 261-268.
37. J. Kirchheiner, R. Lorch, E. Lebedeva, A. Seeringer, I. Roots, J. Sasse and J. Brockmöller, Genetic variants in FKBP5 affect-ing response to antidepressant drug treatment, Pharmacoge-nomics 9 (2008), 841-846.
38. M. Lekman, G. Laje, D. Charney, A.J. Rush, A.F. Wilson, A.J. Sorant, R. Lipsky, S.R. Wisniewski, H. Manji, FJ. McMahon and S. Paddock, The FKBP5-gene in depression and treatment response-an association study in the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) cohort, Biolog-ical Psychiatry 63 (2008), 1103-1110.
39. M. Ising, A.-M. Depping, A. Siebertz, S. Lucae, P.G. Un-schuld, S. Kloiber, S. Horstmann, M. Uhr, B. Müller-Myhsok and F. Holsboer, Polymorphisms in the FKBP5 gene region modulate recovery from psychosocial stress in healthy con-trols. European Journal ofNeuroscience 28 (2008), 389-398.
40. A.F. Hayes, Beyond Baron and Kenny: statistical mediation analysis in the new millennium, Communication Monographs 76 (2009), 408-420.
41. D.P Bernstein, J.A. Stein, M.D. Newcomb, E. Walker, D. Pogge, T. Ahluvalia, J. Stokes, L. Handelsman, M. Medrano, D. Desmond and W. Zule, Development and validation of a brief screening version ofthe childhood trauma questionnaire, Child Abuse and Neglect 27 (2003), 169-190. (Pubitemid 36293325)